Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Seldin

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Cancer Research|December 17, 2005
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cellsSean F Eddy, Shangqin Guo, Elizabeth G Demicco, et al.
Immunology and Cell Biology|September 7, 2011
Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosisAmanda Flies, Tahamtan Ahmadi, Ashley J Parks, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2012
Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary reportJordan T Shin, Jennifer E Ward, Patricia A Collins, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 9, 2013
Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosisLauren Gray Gilstrap, Emily Niehaus, Rajeev Malhotra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftmentAndrew J Cowan, David C Seldin, Martha Skinner, et al.
Haematologica|June 27, 2012
Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experienceAndrew J Cowan, Martha Skinner, David C Seldin, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
American Journal of Hematology|January 6, 2007
Association of acquired von Willebrand syndrome with AL amyloidosisCynthia A Kos, Jennifer E Ward, Karim Malek, et al.
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Cancer Research|December 17, 2005
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cellsSean F Eddy, Shangqin Guo, Elizabeth G Demicco, et al.
Immunology and Cell Biology|September 7, 2011
Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosisAmanda Flies, Tahamtan Ahmadi, Ashley J Parks, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2012
Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary reportJordan T Shin, Jennifer E Ward, Patricia A Collins, et al.
Circulation|December 15, 2015
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort StudyLawreen H Connors, Flora Sam, Martha Skinner, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 9, 2013
Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosisLauren Gray Gilstrap, Emily Niehaus, Rajeev Malhotra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftmentAndrew J Cowan, David C Seldin, Martha Skinner, et al.
Haematologica|June 27, 2012
Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experienceAndrew J Cowan, Martha Skinner, David C Seldin, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
American Journal of Hematology|January 6, 2007
Association of acquired von Willebrand syndrome with AL amyloidosisCynthia A Kos, Jennifer E Ward, Karim Malek, et al.
British Journal of Haematology|June 13, 2002
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisVaishali Sanchorawala, Daniel G Wright, David C Seldin, et al.
Pageof 11